173 related articles for article (PubMed ID: 3540539)
1. Mycobacterial plasmids: screening and possible relationship to antibiotic resistance in Mycobacterium avium/Mycobacterium intracellulare.
Franzblau SG; Takeda T; Nakamura M
Microbiol Immunol; 1986; 30(9):903-7. PubMed ID: 3540539
[No Abstract] [Full Text] [Related]
2. In vitro synergistic activity of ethambutol, isoniazid, kanamycin, rifampin, and streptomycin against Mycobacterium avium-intracellulare complex.
Zimmer BL; DeYoung DR; Roberts GD
Antimicrob Agents Chemother; 1982 Jul; 22(1):148-50. PubMed ID: 7125626
[TBL] [Abstract][Full Text] [Related]
3. Characterization of plasmids from strains of Mycobacterium avium-intracellulare.
Crawford JT; Cave MD; Bates JH
Rev Infect Dis; 1981; 3(5):949-52. PubMed ID: 7339826
[TBL] [Abstract][Full Text] [Related]
4. Plasmid DNA profiles as epidemiological markers for clinical and environmental isolates of Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium scrofulaceum.
Meissner PS; Falkinham JO
J Infect Dis; 1986 Feb; 153(2):325-31. PubMed ID: 3944484
[TBL] [Abstract][Full Text] [Related]
5. Activity of five fluoroquinolones against Mycobacterium avium-intracellulare complex and M. xenopi.
Rastogi N; Goh KS; David HL
Ann Inst Pasteur Microbiol; 1988; 139(2):233-7. PubMed ID: 3165641
[No Abstract] [Full Text] [Related]
6. Plasmid deoxyribonucleic acid and translucent-to-opaque variation in Mycobacterium intracellulare 103.
Mizuguchi Y; Fukunaga M; Taniguchi H
J Bacteriol; 1981 May; 146(2):656-9. PubMed ID: 7217014
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth.
Wallace RJ; Nash DR; Steele LC; Steingrube V
J Clin Microbiol; 1986 Dec; 24(6):976-81. PubMed ID: 3097069
[TBL] [Abstract][Full Text] [Related]
8. [In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains].
Thomas L; Naumann P; Crea A
Immun Infekt; 1986 Nov; 14(6):203-7. PubMed ID: 3100424
[TBL] [Abstract][Full Text] [Related]
9. Combined versus single antituberculosis drugs on the in vitro sensitivity patterns of non-tuberculous mycobacteria.
Banks J; Jenkins PA
Thorax; 1987 Nov; 42(11):838-42. PubMed ID: 3424264
[TBL] [Abstract][Full Text] [Related]
10. The use of DNA probes identifying restriction-fragment-length polymorphisms to examine the Mycobacterium avium complex.
McFadden JJ; Butcher PD; Thompson J; Chiodini R; Hermon-Taylor J
Mol Microbiol; 1987 Nov; 1(3):283-91. PubMed ID: 2896288
[TBL] [Abstract][Full Text] [Related]
11. Two groups of Mycobacterium avium complex strains determined according to the susceptibility to rifampicin and ansamycin.
Tsukamura M
Microbiol Immunol; 1987; 31(7):615-23. PubMed ID: 3125413
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of antibiotic resistance in Mycobacterium intracellulare.
Mizuguchi Y; Udou T; Yamada T
Microbiol Immunol; 1983; 27(5):425-31. PubMed ID: 6312275
[TBL] [Abstract][Full Text] [Related]
13. Comparative in vitro activity of the new macrolide A-56268 against mycobacteria.
Berlin OG; Young LS; Floyd-Reising SA; Bruckner DA
Eur J Clin Microbiol; 1987 Aug; 6(4):486-7. PubMed ID: 2959472
[No Abstract] [Full Text] [Related]
14. Mutational resistance as the mechanism of acquired drug resistance to aminoglycosides and antibacterial agents in Mycobacterium fortuitum and Mycobacterium chelonei. Evidence is based on plasmid analysis, mutational frequencies, and aminoglycoside-modifying enzyme assays.
Wallace RJ; Hull SI; Bobey DG; Price KE; Swenson JM; Steele LC; Christensen L
Am Rev Respir Dis; 1985 Aug; 132(2):409-16. PubMed ID: 4026065
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of rifampin, streptomycin, ethionamide, and ethambutol on Mycobacterium intracellulare.
Heifets LB
Am Rev Respir Dis; 1982 Jan; 125(1):43-8. PubMed ID: 7065508
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of nontuberculous mycobacteria from patients with pulmonary tuberculosis in Ghana.
Otchere ID; Asante-Poku A; Osei-Wusu S; Aboagye SY; Yeboah-Manu D
Int J Mycobacteriol; 2017; 6(1):70-75. PubMed ID: 28317808
[TBL] [Abstract][Full Text] [Related]
17. Rifamycin resistance in mycobacteria.
Cole ST
Res Microbiol; 1996; 147(1-2):48-52. PubMed ID: 8761722
[No Abstract] [Full Text] [Related]
18. Promising new drugs in the treatment of tuberculosis and mycobacteriosis.
Casal M; RodrÃguez F; Gutierrez J; Ruiz P; Benavente MC; Villalba R; Moreno G
J Chemother; 1989 Feb; 1(1):39-45. PubMed ID: 2498468
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility of human and environmental isolates of Mycobacterium avium, M. intracellulare, and M. scrofulaceum to heavy-metal salts and oxyanions.
Falkinham JO; George KL; Parker BC; Gruft H
Antimicrob Agents Chemother; 1984 Jan; 25(1):137-9. PubMed ID: 6230989
[TBL] [Abstract][Full Text] [Related]
20. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to various drugs].
Tomioka H; Sato K; Saito H
Kekkaku; 1991 Jul; 66(7):489-92. PubMed ID: 1890791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
